Lagos, NigeriaFounded 201947+ employeesPrivate
$94.7M raisedSeries A· last: convertible note (Oct 2022)· 8 rounds
Backed by(25 investors)
3 layoff events · Last: Mar 2025
We are an African genomics research, services and development company addressing the need to include under-represented African genomic data in research which could lead to medical breakthroughs and new healthcare solutions worldwide.
